Report post
23andMe, once valued at $6B, has seen a dramatic decline, becoming a penny stock. Its Q4 2024 earnings reveal a dire situation, fighting bankruptcy. CEO Anne Wojcicki's price hikes spark controversy. We explore what went wrong, their current strategy, and the future of ME stock.

The World's Leading Crypto Trading Platform

Get my welcome gifts